BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 18348745)

  • 1. Patient use of dietary supplements: a clinician's perspective.
    Sadovsky R; Collins N; Tighe AP; Brunton SA; Safeer R
    Curr Med Res Opin; 2008 Apr; 24(4):1209-16. PubMed ID: 18348745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
    Brown AC
    Food Chem Toxicol; 2017 Sep; 107(Pt A):449-471. PubMed ID: 27818322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.
    Li W; Wertheimer A
    Innov Pharm; 2023; 14(1):. PubMed ID: 38035313
    [No Abstract]   [Full Text] [Related]  

  • 4. Physicians' understanding of the regulation of dietary supplements.
    Ashar BH; Rice TN; Sisson SD
    Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplements in a national survey: Prevalence of use and reports of adverse events.
    Timbo BB; Ross MP; McCarthy PV; Lin CT
    J Am Diet Assoc; 2006 Dec; 106(12):1966-74. PubMed ID: 17126626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience.
    Schmitz SM; Lopez HL; Mackay D; Nguyen H; Miller PE
    J Diet Suppl; 2020; 17(2):227-248. PubMed ID: 30513022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry.
    Schmitz SM; Lopez HL; MacKay D
    Int J Food Sci Nutr; 2014 Mar; 65(2):129-34. PubMed ID: 24112316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs).
    Pawar RS; Grundel E
    Drug Test Anal; 2017 Mar; 9(3):500-517. PubMed ID: 27259162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of dietary supplements.
    Larsen LL; Berry JA
    J Am Acad Nurse Pract; 2003 Sep; 15(9):410-4. PubMed ID: 14560437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory and ethical issues with dietary supplements.
    Harris IM
    Pharmacotherapy; 2000 Nov; 20(11):1295-302. PubMed ID: 11079277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplements: What's in a name? What's in the bottle?
    Marcus DM
    Drug Test Anal; 2016; 8(3-4):410-2. PubMed ID: 27072845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
    Jiang T
    Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory alerts for dietary supplements in Canada and the United States, 2005-13.
    Abe AM; Hein DJ; Gregory PJ
    Am J Health Syst Pharm; 2015 Jun; 72(11):966-71. PubMed ID: 25987692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(4):1000-50. PubMed ID: 11010621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
    Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
    Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumers' perceptions of the dietary supplement health and education act: implications and recommendations.
    Dodge T
    Drug Test Anal; 2016; 8(3-4):407-9. PubMed ID: 27072844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over the Counter Supplements for Memory: A Review of Available Evidence.
    Hersant H; He S; Maliha P; Grossberg G
    CNS Drugs; 2023 Sep; 37(9):797-817. PubMed ID: 37603263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements.
    Dodge T; Litt D; Kaufman A
    J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dietary supplements for weight loss in the United States: results of a national survey.
    Pillitteri JL; Shiffman S; Rohay JM; Harkins AM; Burton SL; Wadden TA
    Obesity (Silver Spring); 2008 Apr; 16(4):790-6. PubMed ID: 18239570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.